Literature DB >> 212239

Stimulation of amniotic fluid cells by fibroblast growth factor.

L Chettur, E Christensen, J Philip.   

Abstract

Amniotic fluid cells were grown in modified Dulbecco's medium with and without the following additives in different combinations: fibroblast growth factor (FGF), dexamethasone (DME), insulin and cyclic GMP under controlled conditions. Experiments were also conducted with varying amounts of foetal calf serum and FGF to establish optimum levels. Comparative growth, determined by measuring 3H-thymidine uptake, showed that the combination of FGF, DME and insulin in medium with 20% foetal calf serum produced the highest growth rate. These experiments indicate that the culture time of amniotic fluid cells for chromosome studies could be reduced by 25%. FGF did not have any deleterious effect on the chromosomes.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 212239     DOI: 10.1111/j.1399-0004.1978.tb02135.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  4 in total

1.  Treated glass coverslips for in situ culture of amniotic cells: better cell adhesion and growth than on plastic.

Authors:  V Pecile; N Archidiacono; M Rocchi
Journal:  J Med Genet       Date:  1984-04       Impact factor: 6.318

2.  Studies on the origin of human amniotic fluid cells by immunofluorescent staining of keratin filaments.

Authors:  W W Chen
Journal:  J Med Genet       Date:  1982-12       Impact factor: 6.318

3.  Human amniotic fluid cells grown in a hormone-supplemented medium: suitability for prenatal diagnosis.

Authors:  H C Chang; O W Jones; H Masui
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

4.  Influence of vaginal lactoferrin administration on amniotic fluid cytokines and its role against inflammatory complications of pregnancy.

Authors:  Martina Maritati; Manola Comar; Nunzia Zanotta; Silva Seraceni; Alessandro Trentini; Fabrizio Corazza; Fortunato Vesce; Carlo Contini
Journal:  J Inflamm (Lond)       Date:  2017-02-15       Impact factor: 4.981

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.